This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Activity Details
| 541 | Wed, 8/4/2010, 12:30 PM - 1:50 PM | CC-Ballroom D (West) |
| Biopharmaceutical Section P.M. Roundtable Discussion (fee event) — Roundtables PM Roundtable Discussion | ||
| Biopharmaceutical Section | ||
| Organizer(s): Jeffrey Maca, Novartis Pharmaceuticals Corporation | ||
| WL10: | Data Safety Monitoring Boards (DSMB) for International Clinical Trials Sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) — Rebecca DerSimonian, National Institutes of Health | |
| WL11: | Genomics in the Pharmaceutical Industry: Where Is It Headed? — Dhammika Amaratunga, Johnson & Johnson ; James Colaianne, Johnson & Johnson | |
| WL12: | Statistical Issues in Adaptive Design — Wei Zhang, FDA/CVM | |
| WL13: | Multiplicity Issues in Multidomain Patient Reported Outcome (PRO)--Based Endpoints — Mahboob Sobhan, FDA | |
| WL14: | Demonstrating Superiority of Test Drug to Putative Placebo in the Two-Arm Noninferiority Trial — Abdul J. Sankoh, Vertex Pharmaceuticals | |
| WL15: | Careers for a Biostatistician — Katherine Monti, Rho, Inc. | |
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.